Studies related to Symptoms of Schizophrenia and Cannabidiol (CBD) | Examine.com

Cannabidiol (CBD) As An Adjunctive Therapy In Schizophrenia: A Multicenter Randomized Controlled Trial

Effect	Decrease
Trial Design	Randomized trial
Trial Length	1-6 months
Number of Subjects	88
Sex	n/a

Full details on all 2 studies are available to Examine members — On Sale for Black Friday! .

Already a Member? Log in now to access.